Spots Global Cancer Trial Database for stage ivb prostate cancer ajcc v8

Every month we try and update this database with for stage ivb prostate cancer ajcc v8 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis	NCT03317392	Castration-Resi... Metastatic Pros... Stage IVB Prost...	Biopsy Biospecimen Col... Computed Tomogr... Laboratory Biom... Magnetic Resona... Olaparib Quality-of-Life... Radium Ra 223 D...	18 Years -	National Cancer Institute (NCI)
Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer	NCT04754425	Castration-Resi... Castration-Resi... Metastatic Mali... Metastatic Pros... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Biopsy Biospecimen Col... Erdafitinib	18 Years -	M.D. Anderson Cancer Center
Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer	NCT03360721	Castration-Resi... Prostate Adenoc... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Abiraterone Ace... Apalutamide Prednisone	18 Years -	M.D. Anderson Cancer Center
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer	NCT05547386	Castration-Resi... Metastatic Pros... Stage IVB Prost...	Computed Tomogr... Gallium Ga 68 G... Positron Emissi...	18 Years -	Mayo Clinic
Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy	NCT04915508	Prostate Adenoc... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Hormone Therapy Stereotactic Bo...	18 Years -	Jonsson Comprehensive Cancer Center
Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer	NCT03821792	Metastatic Pros... Prostate Adenoc... Prostate Carcin... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Abiraterone Ace... Apalutamide Prednisone	18 Years -	M.D. Anderson Cancer Center
Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer	NCT03649841	Castration-Sens... Metastatic Mali... Metastatic Pros... Prostate Adenoc... Prostate Small ... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Antiandrogen Th... Abiraterone Ace... Prednisone Radiation Thera...	18 Years -	University of Washington
Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer	NCT05733351	Castration-Sens... Metastatic Pros... Stage IVB Prost...	Abiraterone Biospecimen Col... Bone Scan Computed Tomogr... Docetaxel Enzalutamide FDG-Positron Em... Magnetic Resona... PSMA PET Scan Vudalimab	18 Years -	Emory University
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring	NCT05054296	Biochemically R... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Educational Int... Exercise Interv... FitBit Quality-of-Life... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression	NCT04927663	Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... Solid Tumor, Ad... Solid Tumor Metastatic Cast...	Computed Tomogr... Magnetic Resona... Positron Emissi... 11C-YJH08 Optional Tumor ...	18 Years -	University of California, San Francisco
DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers	NCT04388852	Aggressive Vari... Castration-Resi... Metastatic Clea... Metastatic Mali... Metastatic Pros... Metastatic Urot... Stage IV Prosta... Stage IV Renal ... Stage IVA Prost... Stage IVB Prost...	Ipilimumab Valemetostat	18 Years -	M.D. Anderson Cancer Center
Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion	NCT04976257	Prostate Adenoc... Prostate Carcin... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Angiogram Catheterization Gallium Ga-labe... Positron Emissi...	18 Years - 80 Years	University of California, San Francisco
Treatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to Bones	NCT04616547	Castration-Resi... Metastatic Mali... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Questionnaire A... Tin Sn 117m Pen...	18 Years -	National Cancer Institute (NCI)
Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer	NCT05037500	Castration-Resi... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Decitabine and ... Enzalutamide	18 Years -	Roswell Park Cancer Institute
Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate Cancer	NCT04279561	Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Computed Tomogr... Gallium Ga 68 G... Positron Emissi...	18 Years -	Jonsson Comprehensive Cancer Center
Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer	NCT03581500	Prostate Adenoc... PSA Level Great... Stage IIB Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Hyperpolarized ... Magnetic Resona...	-	M.D. Anderson Cancer Center
Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations	NCT05807126	Anatomic Stage ... Castration-Resi... Stage IVB Prost...	Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Magrolimab Olaparib	18 Years -	National Cancer Institute (NCI)
PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery	NCT03218826	Advanced Breast... Advanced Malign... Advanced Prosta... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Castration-Resi... Metastatic Brea... Metastatic Mali... Metastatic Pros... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... Triple-Negative... Unresectable So...	Docetaxel Laboratory Biom... Pharmacological... PI3Kbeta Inhibi...	18 Years -	National Cancer Institute (NCI)
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study	NCT03707574	Advanced Malign... Advanced Melano... Advanced Renal ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage III Color... Stage III Lung ... Stage III Ovari... Stage III Prost... Stage IIIA Colo... Stage IIIA Lung... Stage IIIA Ovar... Stage IIIA Pros... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Colo... Stage IIIB Lung... Stage IIIB Ovar... Stage IIIB Pros... Stage IIIC Colo... Stage IIIC Lung... Stage IIIC Ovar... Stage IIIC Pros... Stage IV Colore... Stage IV Lung C... Stage IV Ovaria... Stage IV Prosta... Stage IVA Color... Stage IVA Lung ... Stage IVA Ovari... Stage IVA Prost... Stage IVB Color... Stage IVB Lung ... Stage IVB Ovari... Stage IVB Prost... Stage IVC Color...	Biospecimen Col...	18 Years -	National Cancer Institute (NCI)
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer	NCT06200103	Castration-Resi... Stage IVB Prost...	Biospecimen Col... Bone Scan Clinical Observ... Computed Tomogr... Gallium Ga 68 G... Lutetium Lu 177... Positron Emissi... Questionnaire A... Single Photon E...	18 Years -	Mayo Clinic
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer	NCT03709550	Castration Leve... Castration-Resi... Metastatic Pros... Prostate Carcin... PSA Level Great... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Decitabine Enzalutamide	18 Years -	Roswell Park Cancer Institute
Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer	NCT03649841	Castration-Sens... Metastatic Mali... Metastatic Pros... Prostate Adenoc... Prostate Small ... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Antiandrogen Th... Abiraterone Ace... Prednisone Radiation Thera...	18 Years -	University of Washington
Gallium-68 PSMA-11 PET in Participants With Prostate Cancer	NCT05034562	Metastatic Pros... Recurrent Prost... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Computed Tomogr... Gallium Ga 68-l... Magnetic Resona... Positron Emissi...	18 Years -	M.D. Anderson Cancer Center
National Cancer Institute "Cancer Moonshot Biobank"	NCT04314401	Acute Myeloid L... Anatomic Stage ... Anatomic Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Lung Non-Small ... Lung Small Cell... Malignant Solid... Metastatic Pros... Multiple Myelom... Stage III Lung ... Stage III Ovari... Stage IV Colore... Stage IV Lung C... Stage IV Ovaria... Stage IV Prosta... Stage IVB Prost...	Biospecimen Col... Medical Chart R...	13 Years -	National Cancer Institute (NCI)
68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer	NCT04050215	Biochemically R... Metastatic Pros... Prostate Adenoc... Prostate Carcin... PSA Level Great... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Computed Tomogr... Gallium Ga 68-l... Positron Emissi... Questionnaire A...	18 Years -	Jonsson Comprehensive Cancer Center
A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors	NCT03784677	Advanced Malign... Refractory Mali... Refractory Ovar... Refractory Panc... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Ovari... Stage III Pancr... Stage III Prost... Stage IIIA Ovar... Stage IIIA Pros... Stage IIIB Ovar... Stage IIIB Pros... Stage IIIC Ovar... Stage IIIC Pros... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IVA Ovari... Stage IVA Prost... Stage IVB Ovari... Stage IVB Prost...	TRPV6 Calcium C...	18 Years -	M.D. Anderson Cancer Center
Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer	NCT05730712	Castration-Resi... Stage IVB Prost...	Biopsy Biospecimen Col... Computed Tomogr... Echocardiograph... Enzalutamide Hyaluronidase-z... Magnetic Resona... Questionnaire A...	18 Years -	Mayo Clinic
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring	NCT05054296	Biochemically R... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Educational Int... Exercise Interv... FitBit Quality-of-Life... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
National Cancer Institute "Cancer Moonshot Biobank"	NCT04314401	Acute Myeloid L... Anatomic Stage ... Anatomic Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Lung Non-Small ... Lung Small Cell... Malignant Solid... Metastatic Pros... Multiple Myelom... Stage III Lung ... Stage III Ovari... Stage IV Colore... Stage IV Lung C... Stage IV Ovaria... Stage IV Prosta... Stage IVB Prost...	Biospecimen Col... Medical Chart R...	13 Years -	National Cancer Institute (NCI)
Efficacy of Ra-223 in PSMA PET Optimally Selected Patients	NCT05924672	Castration-Resi... Metastatic Mali... Stage IVB Prost...	Radium-223 PSMA Positron E... Technetium Tc 9...	18 Years -	University of California, San Francisco
Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies	NCT03217747	Advanced Malign... Castration-Resi... Malignant Solid... Metastatic Mali... Metastatic Pros... Prostate Carcin... Refractory Mali... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Avelumab Ivuxolimab Radiation Thera... Utomilumab	18 Years -	M.D. Anderson Cancer Center
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial	NCT06244004	Castration-Sens... Metastatic Pros... Stage IVB Prost...	Antiandrogen Th... Bone Scan Computed Tomogr... Cytotoxic Chemo... FDG-Positron Em... Radiation Thera...	18 Years -	Northwestern University
68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy	NCT04928820	Biochemically R... Metastatic Mali... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Computed Tomogr... Gallium Ga 68 G... Positron Emissi...	18 Years -	Jonsson Comprehensive Cancer Center
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer	NCT06305598	Castration-Resi... Metastatic Pros... Stage IVB Prost...	Biopsy Bone Scan Computed Tomogr... Leuprolide Acet... Magnetic Resona... Survey Administ... Testosterone Cy...	18 Years -	Roswell Park Cancer Institute
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial	NCT06244004	Castration-Sens... Metastatic Pros... Stage IVB Prost...	Antiandrogen Th... Bone Scan Computed Tomogr... Cytotoxic Chemo... FDG-Positron Em... Radiation Thera...	18 Years -	Northwestern University
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer	NCT03709550	Castration Leve... Castration-Resi... Metastatic Pros... Prostate Carcin... PSA Level Great... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Decitabine Enzalutamide	18 Years -	Roswell Park Cancer Institute
Efficacy of Ra-223 in PSMA PET Optimally Selected Patients	NCT05924672	Castration-Resi... Metastatic Mali... Stage IVB Prost...	Radium-223 PSMA Positron E... Technetium Tc 9...	18 Years -	University of California, San Francisco
Efficacy of Ra-223 in PSMA PET Optimally Selected Patients	NCT05924672	Castration-Resi... Metastatic Mali... Stage IVB Prost...	Radium-223 PSMA Positron E... Technetium Tc 9...	18 Years -	University of California, San Francisco
Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)	NCT05241860	Castration-Sens... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Pharmacotherapy... Follow-Up Questionnaire A... Quality-of-Life...	18 Years -	Alliance for Clinical Trials in Oncology
177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study	NCT05496959	Oligometastatic... Prostate Adenoc... Recurrent Prost... Stage IVB Prost...	Lutetium Lu-177... Quality-of-Life... Stereotactic Bo...	18 Years -	Jonsson Comprehensive Cancer Center
Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer	NCT03821792	Metastatic Pros... Prostate Adenoc... Prostate Carcin... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Abiraterone Ace... Apalutamide Prednisone	18 Years -	M.D. Anderson Cancer Center
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial	NCT06244004	Castration-Sens... Metastatic Pros... Stage IVB Prost...	Antiandrogen Th... Bone Scan Computed Tomogr... Cytotoxic Chemo... FDG-Positron Em... Radiation Thera...	18 Years -	Northwestern University
Gallium-68 PSMA-11 PET in Participants With Prostate Cancer	NCT05034562	Metastatic Pros... Recurrent Prost... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Computed Tomogr... Gallium Ga 68-l... Magnetic Resona... Positron Emissi...	18 Years -	M.D. Anderson Cancer Center
68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer	NCT04716725	Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	68Ga-PSMA-11 Positron Emissi...	18 Years -	University of California, San Francisco
Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer	NCT03751436	Castration Leve... Castration-Resi... Metastatic Pros... Metastatic Pros... Prostate Carcin... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Enzalutamide Venetoclax	18 Years -	Roswell Park Cancer Institute
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes	NCT04501913	Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Hepatobiliary N... Malignant Diges... Malignant Femal... Malignant Genit... Malignant Neopl... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Stage 0 Colorec... Stage 0a Bladde... Stage 0is Bladd... Stage I Bladder... Stage I Cervica... Stage I Colorec... Stage I Ovarian... Stage I Prostat... Stage I Renal C... Stage I Uterine... Stage IA Cervic... Stage IA Ovaria... Stage IA Uterin... Stage IA1 Cervi... Stage IA2 Cervi... Stage IB Cervic... Stage IB Ovaria... Stage IB Uterin... Stage IB1 Cervi... Stage IB2 Cervi... Stage IC Ovaria... Stage II Bladde... Stage II Cervic... Stage II Colore... Stage II Ovaria... Stage II Prosta... Stage II Renal ... Stage II Uterin... Stage IIA Cervi... Stage IIA Color... Stage IIA Ovari... Stage IIA Prost... Stage IIA1 Cerv... Stage IIA2 Cerv... Stage IIB Cervi... Stage IIB Color... Stage IIB Ovari... Stage IIB Prost... Stage IIC Color... Stage IIC Prost... Stage III Bladd... Stage III Cervi... Stage III Color... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Blad... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Ovar... Stage IIIA Pros... Stage IIIA Uter... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Blad... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Ovar... Stage IIIB Pros... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Ovar... Stage IIIC Pros... Stage IIIC Uter... Stage IIIC1 Ute... Stage IIIC2 Ute... Stage IV Bladde... Stage IV Cervic... Stage IV Colore... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Bladd... Stage IVA Cervi... Stage IVA Color... Stage IVA Ovari... Stage IVA Prost... Stage IVA Uteri... Stage IVB Bladd... Stage IVB Cervi... Stage IVB Color... Stage IVB Ovari... Stage IVB Prost... Stage IVB Uteri... Stage IVC Color...	Patient Monitor... Questionnaire A...	18 Years -	City of Hope Medical Center
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer	NCT04734730	Castration-Sens... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Abiraterone Ace... Bicalutamide Degarelix Goserelin Aceta... Leuprolide Acet... Prednisone Questionnaire A... Talazoparib	18 Years -	City of Hope Medical Center
Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study	NCT04585932	Biochemically R... Metastatic Pros... Oligometastatic... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Apalutamide Degarelix Leuprolide Acet... Quality-of-Life... Questionnaire A... Radiation Thera...	18 Years -	M.D. Anderson Cancer Center
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial	NCT05168618	Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Atezolizumab Cabozantinib S-...	18 Years -	University of Utah
Stereotactic Body Radiation Therapy Plus Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy for Treatment of Metastatic, Recurrent Hormone-Sensitive Prostate Cancer, DIVINE Trial	NCT06378866	Recurrent Castr... Stage IVB Prost... Recurrent Prost... Castration-resi...	Abiraterone Apalutamide Biospecimen Col... Bone Scan Computed Tomogr... Darolutamide Degarelix Enzalutamide Goserelin Histrelin Leuprolide Magnetic Resona... Patient Observa... Positron Emissi... Prednisone Questionnaire A... Relugolix Stereotactic Bo... Triptorelin	18 Years -	Mayo Clinic
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer	NCT04734730	Castration-Sens... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Abiraterone Ace... Bicalutamide Degarelix Goserelin Aceta... Leuprolide Acet... Prednisone Questionnaire A... Talazoparib	18 Years -	City of Hope Medical Center
68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer	NCT04716725	Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	68Ga-PSMA-11 Positron Emissi...	18 Years -	University of California, San Francisco
Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV Cancer	NCT04067960	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Biliary Tract C... Clinical Stage ... Clinical Stage ... Malignant Brain... Malignant Genit... Malignant Solid... Pancreatobiliar... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage III Color... Stage III Ovari... Stage III Pancr... Stage III Prost... Stage IIIA Colo... Stage IIIA Ovar... Stage IIIA Pros... Stage IIIB Colo... Stage IIIB Ovar... Stage IIIB Pros... Stage IIIC Colo... Stage IIIC Ovar... Stage IIIC Pros... Stage IV Colore... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IVA Color... Stage IVA Ovari... Stage IVA Pancr... Stage IVA Prost... Stage IVB Color... Stage IVB Ovari... Stage IVB Pancr... Stage IVB Prost... Stage IVC Color...	Biospecimen Col... Genetic Testing Quality-of-Life... Questionnaire A...	-	Mayo Clinic
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging	NCT04423211	Biochemically R... Metastatic Pros... Prostate Adenoc... Stage IVB Prost...	3-Dimensional C... Apalutamide Computed Tomogr... Degarelix External Beam R... Fluciclovine F1... Goserelin Aceta... Intensity-Modul... Intensity-Modul... Leuprolide Acet... Magnetic Resona... Positron Emissi... Quality-of-Life... Questionnaire A... Relugolix Stereotactic Bo... Triptorelin Volume Modulate...	18 Years -	Eastern Cooperative Oncology Group
68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer	NCT04050215	Biochemically R... Metastatic Pros... Prostate Adenoc... Prostate Carcin... PSA Level Great... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Computed Tomogr... Gallium Ga 68-l... Positron Emissi... Questionnaire A...	18 Years -	Jonsson Comprehensive Cancer Center
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer	NCT03709550	Castration Leve... Castration-Resi... Metastatic Pros... Prostate Carcin... PSA Level Great... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Decitabine Enzalutamide	18 Years -	Roswell Park Cancer Institute
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer	NCT03678025	Castration Leve... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Abiraterone Bicalutamide Degarelix Docetaxel Flutamide Goserelin Aceta... Histrelin Aceta... Leuprolide Acet... Nilutamide Orchiectomy Prednisone Quality-of-Life... Radiation Thera... Radical Prostat... Triptorelin	18 Years -	SWOG Cancer Research Network
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer	NCT05547386	Castration-Resi... Metastatic Pros... Stage IVB Prost...	Computed Tomogr... Gallium Ga 68 G... Positron Emissi...	18 Years -	Mayo Clinic
Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy	NCT04915508	Prostate Adenoc... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Hormone Therapy Stereotactic Bo...	18 Years -	Jonsson Comprehensive Cancer Center
Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer	NCT03902951	Metastatic Pros... Prostate Adenoc... Recurrent Prost... Stage IVB Prost...	Abiraterone Ace... Apalutamide Leuprolide Acet... Quality-of-Life... Questionnaire A... Stereotactic Bo...	18 Years -	Jonsson Comprehensive Cancer Center
Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer	NCT03751436	Castration Leve... Castration-Resi... Metastatic Pros... Metastatic Pros... Prostate Carcin... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Enzalutamide Venetoclax	18 Years -	Roswell Park Cancer Institute
Genetic Testing for Men With Metastatic Prostate Cancer	NCT03503097	Metastatic Pros... Stage IV Prosta... Stage IVB Prost...	Biospecimen Col... Genetic Counsel... Genetic Testing Laboratory Biom... Questionnaire	18 Years -	University of Washington
National Cancer Institute "Cancer Moonshot Biobank"	NCT04314401	Acute Myeloid L... Anatomic Stage ... Anatomic Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Lung Non-Small ... Lung Small Cell... Malignant Solid... Metastatic Pros... Multiple Myelom... Stage III Lung ... Stage III Ovari... Stage IV Colore... Stage IV Lung C... Stage IV Ovaria... Stage IV Prosta... Stage IVB Prost...	Biospecimen Col... Medical Chart R...	13 Years -	National Cancer Institute (NCI)
An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer	NCT04134208	Metastatic Pros... Stage IVB Prost...	Computed Tomogr... Fluciclovine F1... Positron Emissi...	18 Years -	M.D. Anderson Cancer Center
177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study	NCT05496959	Oligometastatic... Prostate Adenoc... Recurrent Prost... Stage IVB Prost...	Lutetium Lu-177... Quality-of-Life... Stereotactic Bo...	18 Years -	Jonsson Comprehensive Cancer Center
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial	NCT04693377	Castration-Resi... Metastatic Colo... Metastatic Mali... Metastatic Mali... Metastatic Mela... Metastatic Pros... Metastatic Rena... Metastatic Sarc... Metastatic Thyr... Metastatic Urot... Stage IV Colore... Stage IV Prosta... Stage IV Renal ... Stage IVA Color... Stage IVA Prost... Stage IVB Color... Stage IVB Prost... Stage IVC Color...	Cryosurgery Quality-of-Life... Stereotactic Bo...	18 Years -	M.D. Anderson Cancer Center
Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial	NCT06288113	Castration-Resi... Stage IVB Prost...	Biospecimen Col... Computed Tomogr... Gallium Ga 68 G... Lutetium Lu 177... Positron Emissi... Questionnaire A... Single Photon E...	-	Jonsson Comprehensive Cancer Center
Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer	NCT03999515	Castration-Resi... Double-Negative... Metastatic Pros... Prostate Adenoc... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Abiraterone Ace... Enzalutamide Erdafitinib	18 Years -	University of Washington
Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer	NCT03204812	Castration-Resi... Metastatic Mali... Prostate Adenoc... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Durvalumab Tremelimumab	18 Years -	M.D. Anderson Cancer Center
Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy	NCT05398302	Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Image Guided Bi...	-	Jonsson Comprehensive Cancer Center
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial	NCT06244004	Castration-Sens... Metastatic Pros... Stage IVB Prost...	Antiandrogen Th... Bone Scan Computed Tomogr... Cytotoxic Chemo... FDG-Positron Em... Radiation Thera...	18 Years -	Northwestern University
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer	NCT05113537	Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... Metastatic Cast... Metastatic Cast...	Abemaciclib Lutetium Lu 177...	18 Years -	University of California, San Francisco
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer	NCT05113537	Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... Metastatic Cast... Metastatic Cast...	Abemaciclib Lutetium Lu 177...	18 Years -	University of California, San Francisco
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors	NCT03866382	Bladder Adenoca... Bladder Clear C... Bladder Mixed A... Bladder Neuroen... Bladder Small C... Bladder Squamou... Chromophobe Ren... Collecting Duct... Invasive Bladde... Invasive Bladde... Invasive Bladde... Invasive Bladde... Invasive Bladde... Invasive Bladde... Kidney Medullar... Large Cell Neur... Malignant Testi... Malignant Testi... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Chro... Metastatic Kidn... Metastatic Mali... Metastatic Papi... Metastatic Peni... Metastatic Pros... Metastatic Sarc... Metastatic Uret... Papillary Renal... Sarcomatoid Ren... Stage IV Bladde... Stage IV Penile... Stage IV Renal ... Stage IV Urethr... Stage IVB Prost... Urachal Adenoca... Urethral Clear ...	Bone Scan Cabozantinib S-... Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab Positron Emissi...	18 Years -	National Cancer Institute (NCI)
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer	NCT03678025	Castration Leve... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Abiraterone Bicalutamide Degarelix Docetaxel Flutamide Goserelin Aceta... Histrelin Aceta... Leuprolide Acet... Nilutamide Orchiectomy Prednisone Quality-of-Life... Radiation Thera... Radical Prostat... Triptorelin	18 Years -	SWOG Cancer Research Network
Supraphysiological Androgen to Enhance Chemotherapy Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study	NCT06039371	Castration-Resi... Metastatic Pros... Stage IVB Prost...	Biopsy Biospecimen Col... Bone Scan Carboplatin Computed Tomogr... Etoposide Quality-of-Life... Questionnaire A... Testosterone Cy...	18 Years -	University of Washington

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: